Antibiotic Resistance (ABR) in Neonates with Suspected Sepsis admitted to a Medecins Sans Frontieres (MSF) supported Medium Care Unit in Quetta, Pakistan by Fonseca, M et al.
Abstracts / International Journal of Infectious Diseases 73S (2018) 3–398 123
UMP. 031
Epidemiological, clinical and microbiological
characteristics of nosocomial
extended-spectrum--lactamase-producing
Enterobacteriaceae bacteremia in a tertiary care
public hospital in Buenos Aires, Argentina.
E. Cordova1,∗, V. Roca1, M.I. Lespada1, N.
Gomez2, L. Lopez Moral2, M. Badia2, C.
Rodriguez1
1 Hospital Cosme Argerich, Infectious diseases unit,
Buenos Aires, Argentina
2 Hospital Cosme Argerich, Clinical microbiology
laboratory, Buenos Aires, Argentina
Background: Bloodstream infections caused by extended-
spectrum--lactamase-producing Enterobacteriaceae (ESBL-E) are
commonly encountered in hospitalized patients and may be asso-
ciated with significant mortality. Despite of this, limited clinical
and epidemiological data regarding ESBL-E from Argentina are
available. The aim of our study was to describe epidemiological,
clinical and microbiological characteristics of nosocomial ESBL-
E bacteremia in a tertiary care public hospital in Buenos Aires,
Argentina
Methods & Materials: Single center, descriptive and retro-
spective study (2011-2016). Patients with nosocomial ESBL-E
bacteremia were included. Epidemiological, clinical and micro-
biological characteristics were analyzed. According to national
recommendations for ESBL-E (Red-Whonet/2017), cephalosporins
were considered resistant independently of their MICs. Suscepti-
bility for cefotaxime, ceftazidime and cefepime were also analyzed
according to CLSI breakpoints.
Results: One hundred and seven episodes were included.
Median age 62 (IQR 40-74) years old. Male sex: 64% (IC95 54-
73). Median duration of the previous hospital stay: 11 days (IQR
5–30). Place of acquisition: intensive care unit (ICU) (36%), sur-
gical service (35%) and medical service (29%). Previous use of
antimicrobials was observed in 86% (IC95 78-92) of the patients
and 36% (IC95 27-45) had previous stay in an ICU. The most
frequent origins of infection were: primary bacteremia (35%),
abdominal (28%) and urinary (21%). Median Pitt bacteremia
score (PBS) and Charlson comorbidity index: 4 (IQR 2-4) and 4
(IQR 3-6), respectively. Inappropriate empirical treatment: 37%
(IC95 27-47). Most frequent pathogens: Klebsiella pneumoniae
(75%), Enterobacter spp 15% and Proteus spp (4%). Susceptibil-
ity pattern: ampicillin/sulbactam 0%, piperacillin/tazobactam 16%,
ciprofloxacin 15%, trimethoprim/sulfamethoxazole 13%, amikacin
83%, colistin 92%, imipenem/meropenem 100%. According to CLSI
breakpoints, cefotaxime and ceftazidime were considered suscep-
tible in 0% and 3% respectively. In the case of cefepime 39% and
24% were considered susceptible and dose-dependent susceptible.
Mortality rate (day 14): 30% (IC95 22-40%). Appropriate empiri-
cal treatment decreasedmortality only in patients with PBS ≤4 (OR
0,17 IC950.03-0.92). In themultivariate analysis, only PBS (OR1.91;
IC95 1.25-2.91) was associated with mortality.
Conclusion: Bacteremia caused by ESBL-E was associated with
high mortality. A high-level resistance for piperacillin-tazobactam
and non beta-lactam antimicrobials was observed. Clinical sever-
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Background: Neonatal Sepsis is a major cause of infant death,
especially if associated with ABR. Choice of empirical antibiotics is
particularly challenging without access to culture/DST, as in most
resource limited settings. MSF care included blood cultures (BCs)
since 2015. Here we describe the characteristics of babies, etiolo-
gies, ABR, treatment and outcomes.
Methods & Materials: BC was collected and antibiotics imme-
diately started upon suspicion of sepsis, as perMSF guidelines. ABR
testing was done with disc diffusion test. Proportions were com-
pared with chi-squared test; effect of main antibiotic regimens on
fatality rates (CFR)was assessedusingmultivariable logistic regres-
sion models (likelihood ratio test).
Results: In total 286 babies were admitted (Nov15-Jul17):
93 (32.5%) female; median age: 2 days (IQR:0-6d, range:0-30d),
median gestational age: 37 weeks (IQR:36-38w, range:30-42w);
median weight: 2.3Kgs (IQR:1.8-3.0Kgs, range:1-4.4Kgs), vaginal
delivery: 83.9%; CPAP: 28.6%. Early onset sepsis (EOS) was sus-
pected in 184 (64.3%) and late onset (LOS) in 102 (35.7%); 96 died
(CFR: 34.4%; EOS:38.1%, LOS:26.7%; p=0.05).
Ampicillin +Gentamycinwas themost commonregimenstarted
empirically (238, 83.2%), followed by Cefotaxime+Amkicacin
(24, 8.4%); 86 (30.1%) BCs were positive (CFR: positive 41.7%
versus negative 30.8%, p =0.07), with a total of 103 isolates:
100 (97.1%) bacterial (gram-positive: 61, 61%; gram-negative:
41, 41%) and 3 (2.3%) fungi (Candida spp); 46.6% were poten-
tial skin contaminants (mostly Staphylococcus coagulase-negative).
The most frequent gram-positive pathogen was Enterococcus
sp (9, 8.4%; CFR:44.4%), 37.5% susceptible to Ampicillin (Van-
comycin =100%); as for gram-negatives: Burkholderia cepacia (11,
10.7%; CFR:45.5%), 80%, 90.9% and 100% susceptible to Cotri-
moxazol, Ceftazidime and Meropenem, respectively; Klebsiella
pneumoniae (10, 9.6%; CFR:22.2%) and Escherichia coli (8, 7.9%;
CFR:50%). For all 21 isolates of Enterobacteriaceae (53.8% of all
gram-negatives and 20.4% of all isolates; includes Enterobacter
sp and Proteus mirabilis; CFR:47.6%) susceptibility was: Ceftriax-
one:12.5%; Gentamycin:33.3%; Amikacin:73.6%; Imipenem:82.4%.
After controlling for gestational age, CPAP and c-section, empirical
Cefotaxime+Amikacin was associated with 80% reduction in the
odds of death over Ampicillin +Gentamycin (OR:0.20, 95%CI:0.04-
0.86, p =0.009; N=267).
Conclusion: Culture/DST allows the design of more effec-
tive antibiotic regimens for Neonatal Sepsis which, coupled with
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intensive supportive treatment, prevents fatalities, decreases
infant mortality and may prevent escalation of ABR if coupled with
Antibiotic Stewardship and Infection Prevention and Control.
https://doi.org/10.1016/j.ijid.2018.04.3696
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Background: Brucellosis is one of the most important diseases
among humans and animals. Clinical management of brucellosis
due to an increased rate of treatment failure and recurrence is
extremely worrying. The aim of this study was to determine the
antimicrobial susceptibility pattern of the brucella isolates.
Methods & Materials: From April to September 2014 a total of
30 brucella isolates that were cultured on brucella agar has been
studied. The species identification was carried out and to deter-
mine the effect of antibiotics on bacteria antibiogram testing was
performed by disk diffusion.From April to September 2014 a total
of 30 brucella isolates that were cultured on brucella agar has been
studied. The species identification was carried out and to deter-
mine the effect of antibiotics on bacteria antibiogram testing was
performed by disk diffusion.
Results: In this study, 30 brucella strains were isolated from
cultured specimens and antibiogram testing was performed.
All microbial positive specimens were sequenced by PCR. All
isolates were Brucella melitensis. According to the tests, sucep-
tibility to tetracycline, minocycline, gentamicin, tigecyclin was
100%, to doxycycline 93.3%, co-amoxiclave 66.7%, rifampin 44.7%,
streptomycin 86.7%, ciprofloxacin 80%, cotrimoxazole 76.7% and
ceftriaxone 73.3%.
Conclusion: This study shows that the predominant strain in
our patients was Brucella melitensis. Also, due to high levels of
resistance to rifampin to use the other effective drugs like gentam-
icin, streptomycin, ciprofloxacin or cotrimoxazole in combination
with doxycycline or tetracycline. This study shows that the pre-
dominant strain inourpatientswasBrucellamelitensis. Also, due to
high levels of resistance to rifampin to use the other effective drugs
like gentamicin, streptomycin, ciprofloxacin or cotrimoxazole in
combination with doxycycline or tetracycline.
https://doi.org/10.1016/j.ijid.2018.04.3697
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Background: Although, since 1996, all medications must have
been prescribed by a health professional (doctors or dentists) and
their dispensation supervised by a pharmacist (Law 1737), recently
in February 2017, the State Agency for Medicines and Health Tech-
nology (AGEMED) delivered the statement 00781, “CONTAINMENT
OF ANTIMICROBIAL RESISTANCE”, establishing the obligation to
comply with and apply Law 1737. However, the compliance to this
provision has been irregular. The aim of this study was to deter-
mine the frequency of inappropriate dispensation of antimicrobials
in pharmacies in Santa Cruz de la Sierra, Bolivia when clinical sim-
ulated situations where used (hidden client)
Methods & Materials: A point-prevalence survey, was carried
out between April and June 2017, in pharmacies in Santa Cruz de
la Sierra, Bolivia. Through a simulation technique the antimicro-
bial dispensation was evaluated against two clinical situations: a)
upper acute respiratory infection (URI); b) acute diarrhea (AD).
Students of the last year of Pharmacy career were trained as
patients to simulate the situations described above. Spontaneous
and induced antimicrobial dispensationwas evaluated. In all cases,
the simulation was carried out without medical prescription. The
antimicrobial delivery rate was evaluated as a percentage of the
total contacts. The antimicrobials were grouped by family and by
clinical situation.
Results: Ninety-two pharmacies (86%) out of a total of 107
establishments were evaluated. Eighty (86%) of the pharmacies
were tested by URI simulation and the rest (14%) by AD clinical
situation. Antimicrobials were dispensed in 56 (61%) of the total
simulations (54% spontaneous and 46% induced). In the rest of con-
tacts (39%) the antimicrobials were not dispensed, even after the
induction. While in the URI, the antimicrobials dispensed were:
aminopenicillins (51%); macrolides (38%); Fluoroquinolones (8%)
and cotrimoxazole (2%), in AD, the antimicrobialswere: cotrimoxa-
zole (86%)andnifuroxazide (14%).Dosingerrorswerealsodetected.
Of total antimicrobials, 82%were dispensed bypharmacy assistants
and 18% by pharmacists.
Conclusion: Although in our country there is a norm that
requires thedispensation of antimicrobials exclusively onprescrip-
tion, it was not fulfilled inmost of cases, allowing patients to access
these agents without any control, increasing the risk of adverse
events, drug interactions and development of resistance.
https://doi.org/10.1016/j.ijid.2018.04.3698
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